Akari Therapeutics Plc (AKTX) Cash flow
Market cap
$530.2B
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | - | - | - | 39,944 | 42,400 | 35,848 | 19,205 | 8,907 | 4,126 | 3,708 | 0 | 0 | - |
| Stock-based compensation | 2 | 0 | 1 | 4 | 3 | 2 | 1 | 325,523 | 314,650 | 735,107 | 1 | 2 | 3 |
| Cash from operations | -5 | -9 | -4,965,583 | -24,624,535 | -31,598,709 | -22,580,240 | -12,918,313 | -16,950,408 | -18,846,528 | -21,504,522 | -16 | -13 | -11 |
| Capital expenditures | -0 | -0 | -10,560 | -54,750 | -36,885 | - | - | - | - | - | - | - | - |
| Cash from investing | - | -0 | 1 | -10,066,632 | 10 | - | - | - | - | - | - | 0 | - |
| Cash from financing | 24 | 8 | 69 | - | 16 | 306,232 | 13 | 25 | 14 | 25 | 7 | 11 | 13 |
| Free cash flow | - | - | - | - | - | - |